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Nucleic acid derivatives are involved in cell growth and replication, but they are also
particularly important as building blocks for RNA and DNA synthesis. In nature, purine
and pyrimidine nucleotides are synthesized through two distinct pathways, de novo and
salvage pathways, both depending on 5-phospho-α-D-ribose 1-diphosphate (PRPP) as a key
element [1,2]. In the de novo pathway, purine and pyrimidine nucleotides are synthesized
from simple molecules such as glycine, glutamine, or aspartate. In contrast, the salvage
pathway employs scavenged preformed endogenous or exogenous nucleobases to generate
the corresponding nucleoside-5′-monophosphates (NMPs) [3]. Both metabolic routes, de
novo and salvage pathways, lead to the synthesis of NMPs, which are subsequently phos-
phorylated to obtain the corresponding nucleoside-5′-di (NDPs) and triphosphates (NTPs).
Moreover, all organisms also generate (2′-deoxy)nucleoside-5′-diphosphates (dNDPs) from
NDPs [4], which will be converted to 2′-deoxyribonucleotides (dNTPs), as precursors for
DNA synthesis. Additionally, nucleotide derivatives are involved in cell signaling (cyclic
nucleotides, cNMPs or c-di-NMPs) [5] and a multitude of different biochemical processes,
acting as cofactors (NADP+) or energy sources (ATP).
Due to the importance of the enzymes involved in the synthesis of nucleosides and
nucleotides, they have been extensively studied as potential targets for chemotherapy
against different diseases [1,6] or as important biocatalysts for the synthesis of different
nucleoside and nucleotide analogs [2,7].
This Special Issue will cover the most recent and relevant findings concerning biotech-
nological and biomedical applications of these enzymes. To this end, a total of seven
experimental articles written by world-leading experts were compiled to show the state-of-
the-art.
In the biocatalysis section, glycosyltransferases are the most cited enzymes, and sev-
eral authors focus their attention on this enzyme family. In this respect, Kayushin et al. [8]
developed the preparative synthesis of 2-fluorocordycepin from 2-fluoroadenosine and 3′-
deoxyinosine catalyzed by purine nucleoside phosphorylase from E. coli but also explored
the presence of by-products in this process, providing new insights about this undesirable
effect. Similarly, Rivero et al. performed the sustainable production of cladribine (an FDA-
approved anticancer agent) by a novel 2′-deoxyribosyltransferase (NDT)-based biocatalyst,
including a covalent immobilization of Lactobacillus delbrueckii 2′-deoxyribosyltransferase
(LdNDT) onto glutaraldehyde-activated biomimetic silica nanoparticles followed by biocat-
alyst entrapment in calcium alginate [9]. Finally, similar to that shown above, other authors
displayed the importance of transglycosylation reactions in biocatalysis by exploring the
differences of the enzymatic and chemical syntheses of vacor analogs of nicotinamide
riboside, NMN, and NAD [10].
Moreover, enzymatic cascades play an essential role in this Special Issue, with three
different articles about this topic. In the first one, a study of the possibilities of riboki-
nase (RK)/phosphopentomutase (PPM)/nucleoside phosphorylase (NP) cascades in the
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synthesis of different modified nucleosides was carried out by comparing enzymes from
mesophilic and thermophilic organisms [11]. In another interesting article, Frisch et al.
developed a novel one-pot multi-enzymatic system for the synthesis of 2′-deoxynucleoside-
5′-triphosphates [12]. To this end, an enzymatic cascade comprised of adenine phospho-
ribosyltransferase (APRT), polyphosphate kinase (PPK), and ribonucleotide reductase
(RNR) was successfully employed for the synthesis of cladribine triphosphate from 2-
chloroadenine and 5-phospho-α-D-ribose 1-diphosphate (PRPP) [11]. Finally, to conclude
this subsection, Becker and colleagues [13] developed a multi-enzymatic cascade for the
production of 2′,3′-cGAMP. This four-enzyme cascade is formed by the sequential ac-
tion of adenosine kinase from Saccharomyces cerevisiae (ScADK), polyphosphate kinase 2
from Acinetobacter johnsonii (AjPPK2), PPK2 from Sinorhizobium meliloti (SmPPK2), and a
truncated human cyclic GMP-AMP synthase (tHscGAS). Interestingly the action of the
coupled system ScADK/AjPPK2/SmPPK2 led to the three-step synthesis of ATP from
adenosine, which was subsequently transformed to GMP-AMP (2′,3′-cGAMP) by the
coupled tHscGAS.
Regarding the biomedical applications, Acosta et al. reported the first application
of a 2′-deoxyribosyltransferase (NDT) in suicide gene therapy for cancer treatment, and
also deep into the molecular mechanisms of the hydrolytic ability of LdNDT over dif-
ferent nucleoside-based prodrugs through molecular dynamics simulations. Finally, the
LdNDT/2′-deoxy-2-fluoroadenosine (dFAdo) system was assayed in human cervical cancer
(HeLa) cells with inhibitory concentrations in the low micromolar range [14].
Finally, we would like to thank all the authors, reviewers, and the Editorial Board
members of Biomolecules for their considerable contributions to supporting the implemen-
tation of this special research topic, and we hope that the readers will enjoy their work.
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